These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30101852)

  • 1. Chronic Pressure Overload Induces Cardiac Hypertrophy and Fibrosis via Increases in SGLT1 and IL-18 Gene Expression in Mice.
    Matsushita N; Ishida N; Ibi M; Saito M; Sanbe A; Shimojo H; Suzuki S; Koepsell H; Takeishi Y; Morino Y; Taira E; Sawa Y; Hirose M
    Int Heart J; 2018 Sep; 59(5):1123-1133. PubMed ID: 30101852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Roles of Sodium-Glucose Cotransporter 1 (SGLT1) in the Induction of Cardiac Remodeling].
    Hirose M; Matsushita N; Ishida N; Ibi M; Saito M
    Yakugaku Zasshi; 2018; 138(7):939-943. PubMed ID: 29962473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N; Ma B; Stoll S; Hays TT; Qiu H
    Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
    Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
    Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment with KGA-2727, a selective SGLT1 inhibitor, is protective against myocardial infarction-induced ventricular remodeling and heart failure in mice.
    Sawa Y; Saito M; Ishida N; Ibi M; Matsushita N; Morino Y; Taira E; Hirose M
    J Pharmacol Sci; 2020 Jan; 142(1):16-25. PubMed ID: 31776072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
    Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
    Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice.
    Peters T; Hermans-Beijnsberger S; Beqqali A; Bitsch N; Nakagawa S; Prasanth KV; de Windt LJ; van Oort RJ; Heymans S; Schroen B
    PLoS One; 2016; 11(2):e0150236. PubMed ID: 26919721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic knockdown of cardiac sodium/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice.
    Ramratnam M; Sharma RK; D'Auria S; Lee SJ; Wang D; Huang XY; Ahmad F
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25092788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented endothelial l-arginine transport ameliorates pressure-overload-induced cardiac hypertrophy.
    Rajapakse NW; Johnston T; Kiriazis H; Chin-Dusting JP; Du XJ; Kaye DM
    Exp Physiol; 2015 Jul; 100(7):796-804. PubMed ID: 25958845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload.
    Fontes MS; Kessler EL; van Stuijvenberg L; Brans MA; Falke LL; Kok B; Leask A; van Rijen HV; Vos MA; Goldschmeding R; van Veen TA
    J Mol Cell Cardiol; 2015 Nov; 88():82-90. PubMed ID: 26410398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pressure Overload Impairs Cardiac Function in Long-Chain Fatty Acid Transporter CD36-Knockout Mice.
    Nakatani K; Masuda D; Kobayashi T; Sairyo M; Zhu Y; Okada T; Naito AT; Ohama T; Koseki M; Oka T; Akazawa H; Nishida M; Komuro I; Sakata Y; Yamashita S
    Int Heart J; 2019 Jan; 60(1):159-167. PubMed ID: 30518717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress.
    Zhang B; Zhang P; Tan Y; Feng P; Zhang Z; Liang H; Duan W; Jin Z; Wang X; Liu J; Gao E; Yu S; Yi D; Sun Y; Yi W
    Cell Death Dis; 2019 Jul; 10(7):520. PubMed ID: 31285424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zerumbone prevents pressure overload-induced left ventricular systolic dysfunction by inhibiting cardiac hypertrophy and fibrosis.
    Sari N; Katanasaka Y; Sugiyama Y; Sunagawa Y; Miyazaki Y; Funamoto M; Shimizu S; Shimizu K; Murakami A; Mori K; Wada H; Hasegawa K; Morimoto T
    Phytomedicine; 2021 Nov; 92():153744. PubMed ID: 34563985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
    Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
    Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long pentraxin PTX3 exacerbates pressure overload-induced left ventricular dysfunction.
    Suzuki S; Shishido T; Funayama A; Netsu S; Ishino M; Kitahara T; Sasaki T; Katoh S; Otaki Y; Watanabe T; Shibata Y; Mantovani A; Takeishi Y; Kubota I
    PLoS One; 2013; 8(1):e53133. PubMed ID: 23372656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSDMD-mediated pyroptosis promotes cardiac remodeling in pressure overload.
    You J; Li X; Dai F; Liu J; Zhang Q; Guo W
    Clin Exp Hypertens; 2023 Dec; 45(1):2189138. PubMed ID: 36906959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis.
    Podesser BK; Kreibich M; Dzilic E; Santer D; Förster L; Trojanek S; Abraham D; Krššák M; Klein KU; Tretter EV; Kaun C; Wojta J; Kapeller B; Gonçalves IF; Trescher K; Kiss A
    J Hypertens; 2018 Apr; 36(4):847-856. PubMed ID: 29283973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal Cell-SLIT3/Cardiomyocyte-ROBO1 Axis Regulates Pressure Overload-Induced Cardiac Hypertrophy.
    Liu X; Li B; Wang S; Zhang E; Schultz M; Touma M; Monteiro Da Rocha A; Evans SM; Eichmann A; Herron T; Chen R; Xiong D; Jaworski A; Weiss S; Si MS
    Circ Res; 2024 Mar; 134(7):913-930. PubMed ID: 38414132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.